Myeloid leukemia (C92) ICD-10-CM
The C92 code range covers myeloid leukemia with 41 ICD-10-CM diagnosis codes. 30 of them are billable and valid for claim submission in fiscal year 2027, and the category headers group them but cannot themselves be billed.
Includes
This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- granulocytic leukemia
- myelogenous leukemia
Code Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- , if applicable, pancytopenia acquired D61.818
Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- personal history of leukemia Z85.6
Codes in the C92 Range 41 codes · 30 billable
- C92 Myeloid leukemiaNon-billable
- C92.0 Acute myeloblastic leukemiaNon-billable
- C92.00 Acute myeloblastic leukemia, not having achieved remission
- C92.01 Acute myeloblastic leukemia, in remission
- C92.02 Acute myeloblastic leukemia, in relapse
- C92.1 Chronic myeloid leukemia, BCR/ABL-positiveNon-billable
- C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
- C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission
- C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse
- C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negativeNon-billable
- C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
- C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
- C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
- C92.3 Myeloid sarcomaNon-billable
- C92.30 Myeloid sarcoma, not having achieved remission
- C92.31 Myeloid sarcoma, in remission
- C92.32 Myeloid sarcoma, in relapse
- C92.4 Acute promyelocytic leukemiaNon-billable
- C92.40 Acute promyelocytic leukemia, not having achieved remission
- C92.41 Acute promyelocytic leukemia, in remission
- C92.42 Acute promyelocytic leukemia, in relapse
- C92.5 Acute myelomonocytic leukemiaNon-billable
- C92.50 Acute myelomonocytic leukemia, not having achieved remission
- C92.51 Acute myelomonocytic leukemia, in remission
- C92.52 Acute myelomonocytic leukemia, in relapse
- C92.6 Acute myeloid leukemia with 11q23-abnormalityNon-billable
- C92.60 Acute myeloid leukemia with 11q23-abnormality not having achieved remission
- C92.61 Acute myeloid leukemia with 11q23-abnormality in remission
- C92.62 Acute myeloid leukemia with 11q23-abnormality in relapse
- C92.9 Myeloid leukemia, unspecifiedNon-billable
- C92.90 Myeloid leukemia, unspecified, not having achieved remission
- C92.91 Myeloid leukemia, unspecified in remission
- C92.92 Myeloid leukemia, unspecified in relapse
- C92.A Acute myeloid leukemia with multilineage dysplasiaNon-billable
- C92.A0 Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
- C92.A1 Acute myeloid leukemia with multilineage dysplasia, in remission
- C92.A2 Acute myeloid leukemia with multilineage dysplasia, in relapse
- C92.Z Other myeloid leukemiaNon-billable
- C92.Z0 Other myeloid leukemia not having achieved remission
- C92.Z1 Other myeloid leukemia, in remission
- C92.Z2 Other myeloid leukemia, in relapse
Clinical Terms in This Code Range
Definitions from the National Library of Medicine for conditions coded in the C92 range.
Acute Myeloid Leukemia with MLL Rearrangement in Remission
A finding of acute myeloid leukemia with MLL rearrangement that is not growing and responds to treatment.
Acute Myeloid Leukemia with Multilineage Dysplasia
An acute myeloid leukemia arising de novo and not as a result of treatment. It is characterized by the presence of myelodysplastic features in at least 50% of the cells of at least two hematopoietic cell lines. Patients often present with severe cytopenia.
Acute Myeloid Leukemia with Multilineage Dysplasia in Remission
A finding of acute myeloid leukemia with multilineage dysplasia that is not growing and responds to treatment.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Leukemia, Myeloid
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
Leukemia, Myeloid, Acute
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).
Leukemia, Myelomonocytic, Acute
A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
Leukemia, Promyelocytic, Acute
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement
The reemergence of acute myeloid leukemia with KMT2A rearrangement after a period of remission.
Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
The reemergence of acute myeloid leukemia with multilineage dysplasia after a period of remission.
Sarcoma, Myeloid
An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA.
About the C92 Code Range
Myeloid leukemia involves uncontrolled growth of myeloid cells and their precursors, or immature cells, in bone marrow and other sites.
The subdivisions distinguish acute myeloblastic, promyelocytic, and myelomonocytic leukemia, as well as acute forms with 11q23-abnormality or multilineage dysplasia. Chronic forms separate BCR/ABL-positive leukemia from atypical BCR/ABL-negative leukemia. Other subdivisions cover myeloid sarcoma, unspecified myeloid leukemia, and other myeloid leukemia.
Within each subdivision, codes distinguish disease that has not achieved remission, is in remission, or is in relapse.
Questions About This Page
How many billable codes are in the C92 range?
Of the 41 codes in this range, 30 are billable and valid for claim submission from October 1, 2026 through September 30, 2027. Category header codes group them but cannot be reported on claims.
What does the C92 range classify?
The range classifies myeloid leukemia. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2027 ICD-10-CM Tabular List and order file, effective October 1, 2026 through September 30, 2027.
